King Pharmaceuticals to Webcast Live Conference Call Following Release of First Quarter 2001 Earnings

Apr 17, 2001, 01:00 ET from King Pharmaceuticals, Inc.

    BRISTOL, Tenn., April 17 /PRNewswire/ --
     King Pharmaceuticals, Inc. (NYSE:   KG) reported today that the Company will
 provide a live webcast of its conference call to be held following King's
 announcement of earnings for the first quarter ending March 31, 2001.  As
 previously announced, King plans to announce earnings for the first quarter
 ending March 31, 2001, prior to the market open on Monday, April 30, 2001.
 The earnings release and the related conference call will include a discussion
 of certain financial projections by the Company.
     (Photo: http://www.newscom.com/cgi-bin/prnh/20010125/KGLOGO )
     Interested persons may listen to the conference call on Monday, April 30,
 2001, at 1:00 p.m., E.D.T. at http://www.videonewswire.com/KING/043001/ or by
 dialing 1-800-235-0452 (US only) or 785-832-1077 (international), passcode KP.
 If you are unable to participate during the live webcast, the call will be
 archived on King's web site www.kingpharm.com for not less than 30 days
 following the call.  A replay of the conference call will also be available
 for not less than 30 days following the call by dialing 1-888-566-0175 (US
 only) or 402-530-9314 (international).
     (Minimum requirements to listen to the webcast:  The RealPlayer software,
 downloadable free from www.real.com/products/player/index.html and at least
 14.4 Kbps connection to the internet.  If you experience problems listening to
 the broadcast, send an email to webmaster@vdat.com.)
     King, headquartered in Bristol, Tennessee, is a vertically integrated
 pharmaceutical company that manufactures, markets, and sells primarily branded
 prescription pharmaceutical products.  King seeks to capitalize on
 opportunities in the pharmaceutical industry created by cost containment
 initiatives and consolidation among large global pharmaceutical companies.
 King's strategy is to acquire branded pharmaceutical products and to increase
 their sales by focused promotion and marketing and through product life cycle
 management.
 
 

SOURCE King Pharmaceuticals, Inc.
    BRISTOL, Tenn., April 17 /PRNewswire/ --
     King Pharmaceuticals, Inc. (NYSE:   KG) reported today that the Company will
 provide a live webcast of its conference call to be held following King's
 announcement of earnings for the first quarter ending March 31, 2001.  As
 previously announced, King plans to announce earnings for the first quarter
 ending March 31, 2001, prior to the market open on Monday, April 30, 2001.
 The earnings release and the related conference call will include a discussion
 of certain financial projections by the Company.
     (Photo: http://www.newscom.com/cgi-bin/prnh/20010125/KGLOGO )
     Interested persons may listen to the conference call on Monday, April 30,
 2001, at 1:00 p.m., E.D.T. at http://www.videonewswire.com/KING/043001/ or by
 dialing 1-800-235-0452 (US only) or 785-832-1077 (international), passcode KP.
 If you are unable to participate during the live webcast, the call will be
 archived on King's web site www.kingpharm.com for not less than 30 days
 following the call.  A replay of the conference call will also be available
 for not less than 30 days following the call by dialing 1-888-566-0175 (US
 only) or 402-530-9314 (international).
     (Minimum requirements to listen to the webcast:  The RealPlayer software,
 downloadable free from www.real.com/products/player/index.html and at least
 14.4 Kbps connection to the internet.  If you experience problems listening to
 the broadcast, send an email to webmaster@vdat.com.)
     King, headquartered in Bristol, Tennessee, is a vertically integrated
 pharmaceutical company that manufactures, markets, and sells primarily branded
 prescription pharmaceutical products.  King seeks to capitalize on
 opportunities in the pharmaceutical industry created by cost containment
 initiatives and consolidation among large global pharmaceutical companies.
 King's strategy is to acquire branded pharmaceutical products and to increase
 their sales by focused promotion and marketing and through product life cycle
 management.
 
 SOURCE  King Pharmaceuticals, Inc.